AllianceBernstein
HZNP

AllianceBernstein’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AllianceBernstein’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-459,225
Closed -$53.1M – 3251
2023
Q3 		$53.1M Sell
459,225
-13,290
-3% -$1.43M 0.02% 539
2023
Q2 		$48.6M Buy
472,515
+21,360
+5% +$2.25M 0.02% 580
2023
Q1 		$49.2M Sell
451,155
-15,552
-3% -$1.72M 0.02% 567
2022
Q4 		$53.1M Sell
466,707
-1,029,133
-69% -$85.5M 0.02% 545
2022
Q3 		$92.6M Buy
1,495,840
+1,215,164
+433% +$84.9M 0.04% 378
2022
Q2 		$22.4M Buy
280,676
+171,917
+158% +$16.3M 0.01% 826
2022
Q1 		$11.4M Sell
108,759
-61,197
-36% -$5.96M ﹤0.01% 1153
2021
Q4 		$18.3M Buy
169,956
+55,242
+48% +$6.03M 0.01% 980
2021
Q3 		$12.6M Sell
114,714
-171,488
-60% -$17.8M 0.01% 1126
2021
Q2 		$26.8M Sell
286,202
-1,157
-0.4% -$106K 0.01% 818
2021
Q1 		$26.4M Buy
287,359
+175,448
+157% +$14.8M 0.01% 829
2020
Q4 		$8.19M Sell
111,911
-178,139
-61% -$13.2M ﹤0.01% 1227
2020
Q3 		$22.5M Sell
290,050
-6,031
-2% -$415K 0.01% 765
2020
Q2 		$16.5M Buy
296,081
+157,280
+113% +$6.73M 0.01% 825
2020
Q1 		$4.11M Sell
138,801
-169,249
-55% -$5.73M ﹤0.01% 1277
2019
Q4 		$11.2M Sell
308,050
-17,410
-5% -$534K 0.01% 1048
2019
Q3 		$8.86M Buy
325,460
+28,366
+10% +$733K 0.01% 1101
2019
Q2 		$7.15M Sell
297,094
-86,257
-23% -$2.19M ﹤0.01% 1208
2019
Q1 		$10.1M Sell
383,351
-27,280
-7% -$646K 0.01% 1054
2018
Q4 		$8.02M Sell
410,631
-16,740
-4% -$328K 0.01% 1084
2018
Q3 		$8.37M Buy
427,371
+26,417
+7% +$502K 0.01% 1036
2018
Q2 		$6.64M Buy
400,954
+6,884
+2% +$105K ﹤0.01% 1115
2018
Q1 		$5.6M Buy
394,070
+20,489
+5% +$303K ﹤0.01% 1159
2017
Q4 		$5.45M Buy
373,581
+123,879
+50% +$1.74M ﹤0.01% 1182
2017
Q3 		$3.17M Sell
249,702
-16,318
-6% -$207K ﹤0.01% 1516
2017
Q2 		$3.16M Sell
266,020
-3,798,975
-93% -$47.3M ﹤0.01% 1508
2017
Q1 		$60.1M Buy
4,064,995
+525,486
+15% +$8.51M 0.05% 422
2016
Q4 		$57.3M Buy
3,539,509
+3,286,249
+1,298% +$59.6M 0.05% 413
2016
Q3 		$4.59M Sell
253,260
-8,900
-3% -$174K ﹤0.01% 1166
2016
Q2 		$4.32M Buy
+262,160
New +$4.24M ﹤0.01% 1146
2015
Q2 		– Sell
-86,400
Closed -$2.24M – 3398
2015
Q1 		$2.24M Hold
86,400
– – ﹤0.01% 1646
2014
Q4 		$1.11M Hold
86,400
– – ﹤0.01% 2149
2014
Q3 		$1.06M Hold
86,400
– – ﹤0.01% 2159
2014
Q2 		$1.37M Buy
86,400
+8,658
+11% +$124K ﹤0.01% 2046
2014
Q1 		$1.18M Buy
77,742
+77,546
+39,564% +$876K ﹤0.01% 2070
2013
Q4 		$1K Sell
196
-7,200
-97% -$38.8K ﹤0.01% 3396
2013
Q3 		$25K Sell
7,396
-6,294
-46% -$16.6K ﹤0.01% 3091
2013
Q2 		$34K Buy
+13,690
New +$32.8K ﹤0.01% 3027

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AllianceBernstein's HZNP Position: Q4 2023 in Review

AllianceBernstein sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 459,225 shares — an estimated $53.1M sold.

AllianceBernstein first reported a position in HZNP in Q2 2013 and held it in 38 quarters. The position peaked at $92.6M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • AllianceBernstein reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • AllianceBernstein sold 459,225 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $53.1M.
  • AllianceBernstein first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 38 quarters.
  • AllianceBernstein's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $92.6M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on AllianceBernstein's 13F filing for Q4 2023, filed 14 Feb 2024.